跳至主要内容
临床试验/NCT03092362
NCT03092362已完成不适用

Beat-to-beat Variability in Persistent Atrial Fibrillation

Heart and Diabetes Center North-Rhine Westfalia1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Atrial fibrillation symptoms

研究概览

简要总结

Heart rate variability (HRV) in patients with atrial fibrillation (AF) is hardly studied. Though a reduced HRV in patients with heart failure and reduced ejection fraction (HFrEF) has been associated with poor prognosis. Data on HRV in AF-patients without a reduced ejection fraction is lacking. We hypothesize that those patients with persistent atrial fibrillation and larger beat-to-beat variability would be more symptomatic than does those with smaller HRV. To asses this theory we intend to perform a prospective observational trial. Symptoms of Atrial fibrillation will be assessed using Quality of Life questionnaires and 6 minutes walking test. Heart rate variability will be assessed using 24 hour Holter ECG monitoring.

The correlation between symptoms and heart rate variability will be then assessed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persistent atrial fibrillation
  • No previous ablation for atrial fibrillation
  • At least 18 years old
  • Signed written patient's informed consent

排除标准

  • Paroxysmal atrial fibrillation
  • Previous ablation therapy for atrial fibrillation
  • Reduced left ventricular ejection fraction (LVEF<35%)
  • Permanent ventricular pacing (including cardiac resynchronization therapy CRT)
  • Acute coronary syndrome (ACS) during past 6 weeks.
  • Stroke or TIA within past 6 weeks.
  • Cardiac surgical operation/ intervention within past 3 months.
  • Acute decompensated heart failure
  • Treatment with IV Inotropic medications (e.g. Dobutamine, Levosimendan)
  • Mitral valve replacement or rheumatic mitral valve stenosis
  • Neurological or psychological disease that may impair patient's judgement or compliance
  • Pregnancy or Breast-feeding women.

结局指标

主要结局

Atrial fibrillation symptoms

时间窗: 7 days

Whether atrial fibrillation symptoms assessed by Quality-of-Life questionnaires correlates with heart rate variability

次要结局

  • Atrial fibrillation symptoms(7 days)
  • Improvement in 6MWD (6 minutes walk distance)(7 days)

研究者

发起方
Heart and Diabetes Center North-Rhine Westfalia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验